SEC Filing Update: #TYRA Tyra Biosciences, Inc. : $26.04

Sector: Healthcare | YTD: 🔽 -2.84% The SEC disclosed Today (21-SEP-2026) that BIOTECHNOLOGY VALUE FUND L P has INCREASED #TYRA Shares by 94.15% 🟢 * Previous Holdings: 1.14M Shares * Current Holdings: 2.20M Shares * Increase+1.07M * Increased(%)+94.15% * Ownership: 3.2% * Estimated Investment Value: $26.24M https://www.thinksabio.com/reports/isr/TYRA Institutional ownership in #TYRA has been steadily rising over the past 4 quarters in Shares: Q3 2025: 55.64M Q4 2025: 56.83M Q1 2026: 65.94M Q2 2026: 66.54M 📌 Institutional activity in the last 30 days for #TYRA: • Paradigm Biocapital Advisors LP – Increased holdings by 1,644,846 shares (17-SEP-2026) • RA CAPITAL MANAGEMENT – Increased holdings by 1,931,867 shares (17-SEP-2026) 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2102152352819982702 BIOTECHNOLOGY VALUE FUND L P increased its holdings in Tyra Biotherapeutics from 1,135,053 shares to 2,203,710 shares, representing a 3.2% ownership stake.